Abstract:ObjectiveTo analyze and explore the risk factors of secondary nosocomial infection in uremia and to provide reference for clinical treatment and nursing of uremia.MethodsThe clinical data of 184 uremic patients treated in our hospital from December 2014 to October 2017 were retrospectively analyzed.According to whether hospital infection occurred,all the patientswere divided into the infection group(n=92)and the non-infection group(n=92).And the clinical symptoms and signs of the two groups of patientswere analyzed and compared.Logistic regression was used to analyze the risk factors of nosocomial infection secondary to uremia.ResultsA total of 184 cases of uremic patients sent samples 243 cases,the positive detection rate was 67.08%.Pathogenic bacteria were mainly Klebsiella pneumoniae(31.90%),Pseudomonas aeruginosa(26.38%)and Escherichia coli(15.34%).Secondly,Logistic regression analysis showed that age,presence of dialysis,hyperglycemia,high serum creatinine and high serum albumin were the risk factors of secondary nosocomial infections in uremic patients(OR>1,P<0.05).BMI≥24 kg/m2was the protective factor of secondary nosocomial infection in uremic patients(OR<1,P<0.05).ConclusionSecondary nosocomial infections in uremia are affected bymany factors.It is suggested that targeted interventions should bemade according to the above risk factors and protective factors so as to reduce the incidence of infection.
Yoshida T,Kato J,Inoue I,et al.Cancer development based on chronic active gastritis and resulting gastric atrophy as asssed by serum levels of pepsinogen and Helicobacter pyloriantibody titer[J].Int JCancer,2014,134(6):1445-1457.
[18]
Stenzelius K,Laszlo L,Madeja M,et al.Catheter associated urinary tract infections and other infections in patients hospirealized for acute stroke:aprospective cohort study of two diff erent silicone catheters[J].Scand JUrol,2016(21):1-6.
Yoshida T,Kato J,Inoue I,et al.Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pyloriantibody titer[J].Int JCancer,2014,134(6):1445-1457.